Dr. Elizabeth M. Jaffee

Dr. Elizabeth M. Jaffee, MD, is an internationally renowned medical oncologist and immunotherapy pioneer specializing in pancreatic cancer. She is the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Associate Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and holds the Dana and Albert “Cubby” Broccoli Professorship of Oncology. Dr. Jaffee earned her medical degree from New York Medical College, completed her residency in internal medicine at Presbyterian Hospital in New York, and trained in medical oncology at Johns Hopkins. She is board-certified in Internal Medicine and Medical Oncology and is recognized as one of the foremost leaders in cancer vaccine development.

Dr. Jaffee’s research has centered on developing immunotherapeutic strategies for pancreatic and other gastrointestinal cancers, including peptide vaccines, dendritic cell therapies, and immune checkpoint inhibitors. She has led groundbreaking clinical trials translating laboratory immunology findings into patient care, helping to define the potential for immunotherapy in traditionally treatment-resistant cancers. Her work has resulted in new strategies for integrating immunotherapy into standard oncology practice and has influenced national cancer research priorities.

A past president of the American Association for Cancer Research (AACR), Dr. Jaffee has served on numerous advisory panels for the National Cancer Institute and the Blue Ribbon Panel for the Cancer Moonshot Initiative. She has mentored countless young investigators and is celebrated for her commitment to advancing both science and patient outcomes. Through her visionary leadership, Dr. Elizabeth Jaffee has shaped the field of cancer immunotherapy on a global scale.